BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33791884)

  • 1. How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
    Hadley TD; Agha AM; Ballantyne CM
    Curr Atheroscler Rep; 2021 Apr; 23(6):28. PubMed ID: 33791884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
    de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
    Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Risk Assessment for Atherosclerotic Cardiovascular Disease: A Guide for the General Cardiologist.
    Belanger MJ; Kelly EM; Tahir UA; Benson MD
    Cardiol Rev; 2022 Jul-Aug 01; 30(4):206-213. PubMed ID: 33758125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should We Use Genetic Scores in the Determination of Treatment Strategies to Control Dyslipidemias?
    Lechner K; Kessler T; Schunkert H
    Curr Cardiol Rep; 2020 Sep; 22(11):146. PubMed ID: 32926241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
    Li L; Pang S; Starnecker F; Mueller-Myhsok B; Schunkert H
    Eur Heart J; 2024 May; 45(20):1843-1852. PubMed ID: 38551411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
    Arnold N; Koenig W
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):627-635. PubMed ID: 33156471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
    Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
    Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease.
    Smith JL; Schaid DJ; Kullo IJ
    Curr Atheroscler Rep; 2023 Jun; 25(6):323-330. PubMed ID: 37223852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments.
    Busby GB; Kulm S; Bolli A; Kintzle J; Domenico PD; Bottà G
    Nat Commun; 2023 Nov; 14(1):7105. PubMed ID: 37925478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes.
    Lu T; Forgetta V; Yu OHY; Mokry L; Gregory M; Thanassoulis G; Greenwood CMT; Richards JB
    Cardiovasc Diabetol; 2020 Jan; 19(1):12. PubMed ID: 32000781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cardiovascular disease risk: a 2023 update.
    Goldsborough E; Tasdighi E; Blaha MJ
    Curr Opin Lipidol; 2023 Aug; 34(4):162-173. PubMed ID: 37431303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of incident atherosclerotic cardiovascular disease with polygenic risk of metabolic disease: Analysis of 3 prospective cohort studies in Korea.
    Song H; Koh Y; Rhee TM; Choi SY; Kang S; Lee SP
    Atherosclerosis; 2022 May; 348():16-24. PubMed ID: 35390551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of polygenic risk scores for detection of peripheral artery disease and cardiovascular events.
    Omiye JA; Ghanzouri I; Lopez I; Wang F; Cabot J; Amal S; Ye J; Lopez NG; Adebayo-Tijani F; Ross EG
    PLoS One; 2024; 19(5):e0303610. PubMed ID: 38758931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Cardiovascular Disease Risk: A 2022 Update.
    Goldsborough E; Osuji N; Blaha MJ
    Endocrinol Metab Clin North Am; 2022 Sep; 51(3):483-509. PubMed ID: 35963625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental Value of Polygenic Risk Scores in Primary Prevention of Coronary Heart Disease: A Review.
    Groenendyk JW; Greenland P; Khan SS
    JAMA Intern Med; 2022 Oct; 182(10):1082-1088. PubMed ID: 35994254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family history and polygenic risk of cardiovascular disease: Independent factors associated with secondary cardiovascular events in patients undergoing carotid endarterectomy.
    Timmerman N; de Kleijn DPV; de Borst GJ; den Ruijter HM; Asselbergs FW; Pasterkamp G; Haitjema S; van der Laan SW
    Atherosclerosis; 2020 Aug; 307():121-129. PubMed ID: 32624175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review.
    Khanna NN; Singh M; Maindarkar M; Kumar A; Johri AM; Mentella L; Laird JR; Paraskevas KI; Ruzsa Z; Singh N; Kalra MK; Fernandes JFE; Chaturvedi S; Nicolaides A; Rathore V; Singh I; Teji JS; Al-Maini M; Isenovic ER; Viswanathan V; Khanna P; Fouda MM; Saba L; Suri JS
    J Korean Med Sci; 2023 Nov; 38(46):e395. PubMed ID: 38013648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting.
    Samani NJ; Beeston E; Greengrass C; Riveros-McKay F; Debiec R; Lawday D; Wang Q; Budgeon CA; Braund PS; Bramley R; Kharodia S; Newton M; Marshall A; Krzeminski A; Zafar A; Chahal A; Heer A; Khunti K; Joshi N; Lakhani M; Farooqi A; Plagnol V; Donnelly P; Weale ME; Nelson CP
    Eur Heart J; 2024 Jun; ():. PubMed ID: 38848106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in cardiovascular disease risk factors among older adults in the Hunter Community Study cohort: A comparison of diet quality versus polygenic risk score.
    Reay WR; Haslam R; Cairns MJ; Moschonis G; Clarke E; Attia J; Collins CE
    J Hum Nutr Diet; 2022 Aug; 35(4):675-688. PubMed ID: 35560851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions Between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes, and Lipid Levels.
    Ye Y; Chen X; Han J; Jiang W; Natarajan P; Zhao H
    Circ Genom Precis Med; 2021 Feb; 14(1):e003128. PubMed ID: 33433237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.